TD Cowen Maintains Hold on P3 Health Partners, Raises Price Target to $14
What's Going On With P3 Health Partners Stock Monday?
Lake Street Maintains Buy on P3 Health Partners, Raises Price Target to $14
P3 Health Partners (PIII) Stock Surges Over 42% After Hours: Here's Why
P3 Health Partners (NASDAQ:PIII) Delivers Major Turnaround, Beating Estimates and Raising Guidance
Full Transcript: P3 Health Partners Q1 2026 Earnings Call
P3 Health Partners Narrows FY2026 Sales Guidance from $1.500B-$1.700B to $1.500B-$1.650B vs $1.539B Est
P3 Health Partners Q1 EPS $(1.72) Beats $(3.28) Estimate, Sales $386.390M Miss $391.500M Estimate
P3 Health Partners Schedules First Quarter 2026 Earnings Release and Conference Call
TD Cowen Maintains Hold on P3 Health Partners, Lowers Price Target to $3
Lake Street Maintains Buy on P3 Health Partners, Lowers Price Target to $4
P3 Health Partners Announces Fourth Quarter and Full Year 2025 Results
P3 Health Partners Sees FY2026 Sales $1.500B-$1.700B vs $1.645B Est
P3 Health Partners Q4 EPS $(23.02) Misses $(9.46) Estimate, Sales $384.814M Beat $357.650M Estimate
P3 Health Partners Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call
How Recent Developments Are Reframing The P3 Health Partners (PIII) Investment Story
Why The Narrative Around P3 Health Partners Is Shifting After Recent Q3 Weakness And Outlook Reset
What The Latest Outlook Shift Means For P3 Health Partners Valuation
P3 Expands Footprint Through Joint Venture With Commonwealth Primary Care ACO
P3 Health Partners, Commonwealth Primary Care Form JV For ACO Lines Of Businesses To Expand Value-Based Care, Enhance Support For Primary Care Physicians Throughout Arizona, California, Nevada, Oregon, and North Carolina
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.